Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

U.S. FDA issues recall of Ethicon’s surgical staplers

The U.S. Food and Drug Administration issued a recall of surgical staplers made by Johnson & Johnson’s Ethicon unit, warning that the use of the devices could cause serious injury or death.

Read More »

Future of Healthcare

I got into Healthcare six years ago and canvassed major events to gain a consensus on what the future held.

Read More »

J&J agrees to pay about $1 billion to resolve hip implant lawsuits: Bloomberg

Johnson & Johnson agreed to pay about $1 billion to resolve the bulk of lawsuits claiming the company sold defective metal-on-metal hip implants that ultimately had to be removed, Bloomberg reported, citing people with knowledge of the matter.

Read More »

GSK’s 3-in-1 inhalable drug shows promise in asthma study

GlaxoSmithKline Plc said the company’s three-in-one drug Trelegy Ellipta met the main goal of a late-stage asthma study, signaling a possible boost to the British drugmaker’s lung medicines division.

Read More »

Reports: Odds of Getting Drugs to Market Range from 6% to 40%

A recent report written by SVB Leerink analysts that looked at eight companies and their research-and-development portfolios found that in the past five years, they progressed only 24 percent of their new molecular entities to approval.

Read More »

Abbott, the U.S. Department of Defense and TRACK-TBI Partner to Study Point-of-Care Blood Test for Concussions

Abbott announced the next phase of partnership with the U.S. Department of Defense and researchers from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Network, one of the largest traumatic brain injury efforts of its kind.

Read More »

3D goggles may soon help surgeons see better

In a first, heart surgeons in Poland used 3D goggles to help them see inside a patient’s chest as they opened up a narrowed heart valve, according to a report in the European Heart Journal.

Read More »

March Madness: “The Fabulous 5” Life Science IPOs

March 2019 was a busy month for biopharma and medical device company initial public offerings.

Read More »

Integra gets FDA warning letter for Boston plant

Integra Lifesciences Holdings Corp. received a warning letter from the U.S. Food and Drug Administration regarding the medical device maker ‘s manufacturing facility in Boston.

Read More »

FDA Grants Breakthrough Designation to Paige.AI

Paige.AI was granted Breakthrough Device designation by the U.S. Food and Drug Administration, the first such designation for AI in cancer diagnosis publicly announced by any company.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom